In multivariate analysis, the presence of pre-treatment higher total NKG2D expression, along with previous HCC history and non-SVR, was found to be significantly associated with early-emerging HCC, after adjustment for age, sex, AFP, FIB-4 score, and/or serum albumin (Table 3) in various models. The gene discussed is ALB; the disease is hepatocellular carcinoma.